Cleared Traditional

DR-HO's Back Pain Relief System Pro (Models BPRS-I and BPRS-II) (K202671) - FDA 510(k) Clearance

Class II Physical Medicine device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K202671 · Guangzhou Xinbo Electronic Co., Ltd. · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2021
Decision
424d
Days
Class 2
Risk

K202671 is an FDA 510(k) clearance for the DR-HO's Back Pain Relief System Pro (Models BPRS-I and BPRS-II). Classified as Stimulator, Nerve, Transcutaneous, Over-the-counter (product code NUH), Class II - Special Controls.

Submitted by Guangzhou Xinbo Electronic Co., Ltd. (Guangzhou, CN). The FDA issued a Cleared decision on November 12, 2021 after a review of 424 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 882.5890 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Physical Medicine submissions.

View all Guangzhou Xinbo Electronic Co., Ltd. devices

Submission Details

510(k) Number K202671 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 14, 2020
Decision Date November 12, 2021
Days to Decision 424 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
309d slower than avg
Panel avg: 115d · This submission: 424d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NUH Stimulator, Nerve, Transcutaneous, Over-the-counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
Definition Temporary Relief Of Pain Due To Sore/aching Muscles
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.

Regulatory Consultant

Guangzhou GLOMED Biological Technology Co., Ltd.
Cassie Lee

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NUH Stimulator, Nerve, Transcutaneous, Over-the-counter

All 133
Devices cleared under the same product code (NUH) and FDA review panel - the closest regulatory comparables to K202671.
Transcutaneous Electrical Nerve Stimulator
K210223 · Top-Rank Health Care Co., Ltd. · Dec 2021
Heat StimPlus
K212918 · Famidoc Technology Co., Ltd. · Dec 2021
Low-frequency Stimulator (Model: AST-645, AST-646)
K212989 · Shenzhen Osto Technology Co., Ltd. · Nov 2021
HIVOX OTC Electrical Stimulator, FT610-B
K211403 · Hivox Biotek, Inc. · Oct 2021
Smart Neck Stimulator
K200558 · Guandong Skg Intelligent Technology Co., Ltd. · Oct 2021
Electronic Muscle Stimulator (Model: AST-300A, AST-300N, AST-300S, AST-300T, AST-300V, AST-300W)
K211736 · Shenzhen Osto Technology Company Limited · Sep 2021